| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |